Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic MiniMed Consumer CGMS PMA Supplement To Be Refiled In Dec.

This article was originally published in The Gray Sheet

Executive Summary

Medtronic MiniMed's proposed labeling for the consumer version of its continuous glucose monitoring system (CGMS) "will not be as aggressive" as the firm originally planned, President Terry Gregg said Sept. 25 at an institutional investor conference in Minneapolis.

You may also be interested in...



Continuous Glucose Monitoring: TheraSense Targets Medtronic/MiniMed

TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004

Continuous Glucose Monitoring: TheraSense Targets Medtronic/MiniMed

TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004

Biosensor Technology To Monitor Aging Processes Needed – NIH

The National Institute on Aging hopes to fund the development of non-invasive biosensor monitors to track the aging process, according to NIA Geriatrics Health Program Specialist Winifred Rossi

Related Content

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel